Professor | Liang Wen | Asia Growth Partners

	Upload Avatar (500 x 500)
Name	Liang Wen
Contact Information	11518214@zju.edu.cn
Language ability	English, Chinese
Province	Zhejiang

Upload Avatar (500 x 500)

Name

Liang Wen

Contact Information

11518214@zju.edu.cn

Language ability

English, Chinese

Province

Zhejiang

University/Lab Affiliation and Title	Zhejiang University
Faculty	Medical
Academic Background & Achievements	Ph.D. in Surgery: Zhejiang University Joint Ph.D. Program: University of California, San Diego (UCSD) Guest Associate Editor: Frontiers in Medicine
Work Experience	Current - Zhejiang University School of Medicine, First Affiliated Hospital - Attending Physician Current - Zhejiang University School of Medicine - Class Advisor for MBBS Class of 2021 Current - Zhejiang University Pancreatic Disease Research Key Laboratory - Team Member

University/Lab Affiliation and Title

Zhejiang University

Faculty

Medical

Academic Background & Achievements

Ph.D. in Surgery: Zhejiang University
Joint Ph.D. Program: University of California, San Diego (UCSD)
Guest Associate Editor: Frontiers in Medicine

Work Experience

Current - Zhejiang University School of Medicine, First Affiliated Hospital - Attending Physician
Current - Zhejiang University School of Medicine - Class Advisor for MBBS Class of 2021
Current - Zhejiang University Pancreatic Disease Research Key Laboratory - Team Member

Areas of Focus	Liver Cancer Drug Resistance Tumor Immunotherapy Gut Microbiota
Publications	An Efficient Combination Immunotherapy for Primary Liver Cancer by Harmonized Activation of Innate and Adaptive Immunity, Wen L, Xin B, Wu P, Lin C, Peng C, Wang G, Lee J, Lu L and Feng S, 2019 Gut flora disequilibrium promotes the initiation of liver cancer by modulating tryptophan metabolism and up-regulating SREBP2, Chen W, Wen L, Bao Y, Tang Z, Zhao J, Zhang X, Wei T, Zhang J, Ma T, Zhang Q, Zhi X, Li J, Zhang C, Ni L, Li M, Liang T, 2022 Regulation of Multi-drug Resistance in hepatocellular carcinoma cells is TRPC6/Calcium Dependent, Wen L, Liang C, Chen E, Chen W, Liang F, Zhi X, Wei T, Xue F, Li G, Yang Q, Gong W, Feng X, Bai X and Liang T, 2016 Sintilimab-Induced Autoimmune Diabetes in a Patient With the Anti-tumor Effect of Partial Regression, Wen L, Zou X, Chen Y, Bai X, Liang T, 2020 Sintilimab-induced Alopecia Universalis in a Patient With the Anti-tumor Effect of Complete Remission After Hepatectomy, Wen L, Zhao J, Yang Y, Chen W, Bao Y, Zhang J, Wei T, Zhou L, Xi B, Zhang Y, Liang T, 2023 Interplay between myeloid-derived suppressor cells (MDSCs) and Th17 cells: foe or friend?, Wen L, Gong P, Liang C, Shou D, Liu B, Chen Y, Bao C, Chen L, Liu X, Liang T and Gong W, 2016 The PD-1/PD-L1 pathway in murine hair cycle transition: a potential anagen phase regulator, Zhou L, Wen L, Sheng Y, Lu J, Hu R, Wang X, Lu Z and Yang Q, 2021 Case report: A case of heterogeneity of the antitumor response to immune checkpoint inhibitors in a patient with relapsed hepatocellular carcinoma, Bao Y, Wen L, Chen W, Zhao J, Yang Y, Wei T, Zhang J and Liang T, 2022 Suppressive role of myeloid-derived suppressor cells (MDSCs) in the microenvironment of breast cancer and targeted immunotherapies, Shou D, Wen L, Song Z, Yin J, Sun Q and Gong W, 2016 Interplay between chronic kidney disease (CKD) and upper tract urothelial carcinomas (UUC): foe or friend?, Han Y, Shou D, Wen L*, Shi J, Ding J, Gong P and Gong W, 2016

Areas of Focus

Liver Cancer Drug Resistance
Tumor Immunotherapy
Gut Microbiota

Publications

An Efficient Combination Immunotherapy for Primary Liver Cancer by Harmonized Activation of Innate and Adaptive Immunity, Wen L, Xin B, Wu P, Lin C, Peng C, Wang G, Lee J, Lu L and Feng S, 2019
Gut flora disequilibrium promotes the initiation of liver cancer by modulating tryptophan metabolism and up-regulating SREBP2, Chen W*, Wen L*, Bao Y, Tang Z, Zhao J, Zhang X, Wei T, Zhang J, Ma T, Zhang Q, Zhi X, Li J, Zhang C, Ni L, Li M, Liang T, 2022
Regulation of Multi-drug Resistance in hepatocellular carcinoma cells is TRPC6/Calcium Dependent, Wen L*, Liang C*, Chen E, Chen W, Liang F, Zhi X, Wei T, Xue F, Li G, Yang Q, Gong W, Feng X, Bai X and Liang T, 2016
Sintilimab-Induced Autoimmune Diabetes in a Patient With the Anti-tumor Effect of Partial Regression, Wen L, Zou X, Chen Y, Bai X, Liang T, 2020
Sintilimab-induced Alopecia Universalis in a Patient With the Anti-tumor Effect of Complete Remission After Hepatectomy, Wen L, Zhao J, Yang Y, Chen W, Bao Y, Zhang J, Wei T, Zhou L, Xi B, Zhang Y, Liang T, 2023
Interplay between myeloid-derived suppressor cells (MDSCs) and Th17 cells: foe or friend?, Wen L*, Gong P*, Liang C, Shou D, Liu B, Chen Y, Bao C, Chen L, Liu X, Liang T and Gong W, 2016
The PD-1/PD-L1 pathway in murine hair cycle transition: a potential anagen phase regulator, Zhou L*, Wen L*, Sheng Y, Lu J, Hu R, Wang X, Lu Z and Yang Q, 2021
Case report: A case of heterogeneity of the antitumor response to immune checkpoint inhibitors in a patient with relapsed hepatocellular carcinoma, Bao Y*, Wen L*, Chen W, Zhao J, Yang Y, Wei T, Zhang J and Liang T, 2022
Suppressive role of myeloid-derived suppressor cells (MDSCs) in the microenvironment of breast cancer and targeted immunotherapies, Shou D*, Wen L*, Song Z, Yin J, Sun Q and Gong W, 2016
Interplay between chronic kidney disease (CKD) and upper tract urothelial carcinomas (UUC): foe or friend?, Han Y*, Shou D*, Wen L*, Shi J, Ding J, Gong P and Gong W, 2016

Liver Cancer Drug Resistance Immunotherapy Tumor Cancer Microbiota Gut Research Clinical Translational

Fan Jia - Fudan University

Linrong Lu - Zhejiang University

Qingqing Wang - Zhejiang University

View All

Personal Information

Academic Information

Research

Contact us

No account yet?

Personal Information

Academic Information

Research

Contact us